Session 2A: Formulation and Analytical Aspects of a Pediatric Dosage FormMini Tablets Presentations

1-Speaker Introductions: Elizabeth Galella, MS 2-Overview of the Mini Tablet Formulation with a Focus on Nomenclature: Stuart Charlton, PhD 3-Tablets and Drug Product Nomenclature: LCDR Jibril Abdus-Samad, PharmD 4-Mini Tablet Manufacturing Challenges: Katie Metzler, MS 5-Navigating Packaging Challenges for Mini Tablets: Kirsten O’Brien, BS 6-Food Selection, Compatibility and Testing Strategies: Anna Externbrink, PhD 7-Case Studies: Enteral Tube Administration of Mini Tablets: Yemin Liu, PhD 8-Mini Tablet User Experience: Smita Salunke, PhD

Session 2B:Form & Analytical Aspects of a Ped Dosage Form Excipients for Ped Form Panel Discuss
▶︎

Session 2B:Form & Analytical Aspects of a Ped Dosage Form Excipients for Ped Form Panel Discuss

Session 1:  Biopharmaceutics Risk Assessment Framework
▶︎

Session 1: Biopharmaceutics Risk Assessment Framework

Session 2B:Form & Analytical Aspects of a Pediatric Dosage Form Excipients for Pediatric Form
▶︎

Session 2B:Form & Analytical Aspects of a Pediatric Dosage Form Excipients for Pediatric Form

Prediabetes is reversible. Here's exactly how.
▶︎

Prediabetes is reversible. Here's exactly how.

How to understand native speakers when they talk quickly: Live English Class
▶︎

How to understand native speakers when they talk quickly: Live English Class

Why AI Tokens are so Expensive - Computerphile
▶︎

Why AI Tokens are so Expensive - Computerphile

Session 2A: Formulation & Analytical Aspects of a Pediatric Dosage FormMini Tablets Panel Discussion
▶︎

Session 2A: Formulation & Analytical Aspects of a Pediatric Dosage FormMini Tablets Panel Discussion

Nervous System Regulation (999 Hz) | 1 hour handpan music | Malte Marten
▶︎

Nervous System Regulation (999 Hz) | 1 hour handpan music | Malte Marten

🫀 2025 BLS Practice Test | CPR & AED Practice Test with Detailed Answers
▶︎

🫀 2025 BLS Practice Test | CPR & AED Practice Test with Detailed Answers

Session 3:Medium Risk Drug Products-How to Use Biopharmaceutics Tool to Understand and Mitigate Risk
▶︎

Session 3:Medium Risk Drug Products-How to Use Biopharmaceutics Tool to Understand and Mitigate Risk

Opening Session Presentations and Session 1A: Patient-Centricity Session Presentations
▶︎

Opening Session Presentations and Session 1A: Patient-Centricity Session Presentations

Canada Faces Trump's Wrath as China Gets Spared; GOP Mocked for Olive Garden Analogy: A Closer Look
▶︎

Canada Faces Trump's Wrath as China Gets Spared; GOP Mocked for Olive Garden Analogy: A Closer Look

Diet Therapy for Adults and Children with Epilepsy
▶︎

Diet Therapy for Adults and Children with Epilepsy

Mayor Zohran Mamdani on Socialism, Politics & NYC | The Weekly Show with Jon Stewart
▶︎

Mayor Zohran Mamdani on Socialism, Politics & NYC | The Weekly Show with Jon Stewart

CITC 2024 – D1S02 – Basics of Clinical Trial Design
▶︎

CITC 2024 – D1S02 – Basics of Clinical Trial Design

Session 4: Low and Very Low Risk Products-What is Needed and What is Not
▶︎

Session 4: Low and Very Low Risk Products-What is Needed and What is Not

How China Is Beating Anthropic and OpenAI At Their Own Game.
▶︎

How China Is Beating Anthropic and OpenAI At Their Own Game.

Session 1B: Patient-Centricity Presentations
▶︎

Session 1B: Patient-Centricity Presentations

Understand AI in 14 minutes – with Anthropic's Chloe Lubinski [ARC 2026]
▶︎

Understand AI in 14 minutes – with Anthropic's Chloe Lubinski [ARC 2026]

Cringe Inducing Triage Notes - Amal Mattu, MD
▶︎

Cringe Inducing Triage Notes - Amal Mattu, MD